Thermo Fisher Scientific launches CorEvitas Obesity Registry
Registry developed to advance real-world evidence in treatment outcomes
Registry developed to advance real-world evidence in treatment outcomes
Chromeleon™ 7.4 unifies chromatography and MS data in one streamlined, scalable platform – enabling remote access, centralized storage, full traceability, and automated compliance features for labs in biopharma, food safety, and environmental testing
For fast, non-destructive at-line testing in pharmaceutical and industrial environments
New state-of-the-art facility in Philadelphia provides integrated lab and collaboration space along with tailored guidance to help move advanced therapies from early research to clinical readiness
6,000-square-foot facility enables clinical and commercial process development support to help cell therapy developers transition from research-scale to commercialization
New SwiftArrayStudio analyzer and updated genotyping arrays deliver results in as little as 30 hours, enabling researchers to drive impactful, scalable genetic research
New and expanded facilities provide local expertise, advanced technologies and tailored support for biopharma innovators throughout the region
New formulations simplify microbial bioprocessing, helping innovators scale plasmid DNA and protein production with confidence
New solution uses automated 3D metrology to increase productivity in fabrication environments
Next-generation HEK293 transient expression system is driving breakthroughs in therapeutic development
As part of the agreement, Thermo Fisher will manage the sales, distribution, and customer support for Massbox in Europe and China
Kit enables genomic, transcriptomic and proteomic analysis from a single sample to support cancer and disease research
Designed to enable scientists to conduct small-scale experiments quickly and affordably
First-of-its-kind bench scale bioreactor enabling productivity, scalability and efficiency supporting reduced environmental impact
The new genetic analyzer supports both clinical as well as research for Sanger sequencing and fragment analysis in targeted genomic testing
General purpose centrifuges with next-generation natural refrigerant cooling system
The Invitrogen™ TaqMan™ Cells-to-CT™ HepatoExpress Kit lets researchers measure gene activity in liver cells without doing RNA purification, so they can go from sample to results in about 75 minutes, with only 10 minutes of hands-on work
Highly complementary technologies strengthen Thermo Fisher’s portfolio in bioprocessing and adjacent markets
To help simulate exact environmental conditions for shipping, storage, or research environments, offering repeatable and consistent performance